2019
DOI: 10.1016/j.diabres.2019.107904
|View full text |Cite
|
Sign up to set email alerts
|

Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 33 publications
1
6
0
Order By: Relevance
“…In the study of Jin et al (35), which looked at two groups of patients with different therapies, associations between C-peptide and SD or CV appear to be significant in T2D patients under insulin therapy, whereas same associations are lost when looking at T2D patients without insulin therapy. The same conclusions about insulin treatment and C-peptide association with CV or SD are provided by Christensen et al (37), Huang et al (39), and Ohara et al (90).…”
Section: Relationships Between Gv Parameters and T2d Related Markerssupporting
confidence: 71%
“…In the study of Jin et al (35), which looked at two groups of patients with different therapies, associations between C-peptide and SD or CV appear to be significant in T2D patients under insulin therapy, whereas same associations are lost when looking at T2D patients without insulin therapy. The same conclusions about insulin treatment and C-peptide association with CV or SD are provided by Christensen et al (37), Huang et al (39), and Ohara et al (90).…”
Section: Relationships Between Gv Parameters and T2d Related Markerssupporting
confidence: 71%
“…Body mass index (BMI), SBP and DBP were measured and FBG, HbA1c (NGSP), LDL-C, HDL-C, triglycerides, fasting C-peptide and the 6-min value of C-peptide after glucagon (1 mg) stimulation test (stimulated C-peptide) were measured by standard methods as described previously [ 53 ].…”
Section: Methodsmentioning
confidence: 99%
“…Therefore, it is plausible to postulate that glycemic variability may partially account for the significant association between 1,5-anhydroglucitol and ACPR. In accord, a recent study demonstrated that several measures of glycemic variability assessed by continuous glucose monitoring were significantly linked to glucagon-stimulated insulin secretion in Japanese patients with type 2 diabetes [ 32 ].…”
Section: Discussionmentioning
confidence: 99%